Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -45.63% is 56% above its 5-year average of -103.46%, near the high end of its 5-year range (-189.42%–-45.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.04% above its 12-month average of -57.07%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -45.63%.
RETURN ON INVESTED CAPITAL (ROIC)
-45.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-57.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-84.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-103.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-85.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+20.04%
CURRENT VS 3Y AVG
+45.92%
CURRENT VS 5Y AVG
+55.89%
CURRENT VS 10Y AVG
+46.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-27.97%
vs the sector median at left
ImmunityBio, Inc.
Market Cap
$10.15B
Return on Invested Capital (ROIC)
-45.63%
TTM Avg
-57.07%
3Y Avg
-84.39%
5Y Avg
-103.46%
Market Cap
$10.13B
Return on Invested Capital (ROIC)
8.90%
TTM Avg
10.00%
3Y Avg
10.19%
5Y Avg
11.72%
Market Cap
$10.19B
Return on Invested Capital (ROIC)
3.56%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.24B
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-18.31%
3Y Avg
-21.75%
5Y Avg
-17.22%
Market Cap
$10.03B
Return on Invested Capital (ROIC)
7.29%
TTM Avg
7.04%
3Y Avg
6.95%
5Y Avg
7.54%
Market Cap
$10.31B
Return on Invested Capital (ROIC)
10.49%
TTM Avg
5.87%
3Y Avg
5.79%
5Y Avg
6.13%
Market Cap
$9.93B
Return on Invested Capital (ROIC)
1.54%
TTM Avg
2.53%
3Y Avg
2.92%
5Y Avg
2.77%
Market Cap
$10.40B
Return on Invested Capital (ROIC)
-24.57%
TTM Avg
-32.39%
3Y Avg
-30.66%
5Y Avg
-30.79%
Market Cap
$9.87B
Return on Invested Capital (ROIC)
1.85%
TTM Avg
0.17%
3Y Avg
2.33%
5Y Avg
3.34%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.15B | -45.63% | -57.07% | -84.39% | -103.46% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 8.90% | 10.00% | 10.19% | 11.72% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 3.56% | 12.01% | 15.07% | 15.28% |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | -9.57% | -18.31% | -21.75% | -17.22% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 7.29% | 7.04% | 6.95% | 7.54% |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 10.49% | 5.87% | 5.79% | 6.13% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 1.54% | 2.53% | 2.92% | 2.77% |
| Twist Bioscience Corporation (TWST)vs › | $10.40B | -24.57% | -32.39% | -30.66% | -30.79% |
| Repligen Corporation (RGEN)vs › | $9.87B | 1.85% | 0.17% | 2.33% | 3.34% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 6.53% | 6.69% | 7.80% | 8.31% |
ROIC
-45.6%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -45.63% |
| 2026-03-31 | -45.10% |
| 2025-12-31 | -56.97% |
| 2025-09-30 | -56.46% |
| 2025-06-30 | -81.20% |
| 2025-03-31 | -123.12% |
| 2024-12-31 | -104.94% |
| 2024-09-30 | -118.63% |
| 2024-06-30 | -94.20% |
| 2024-03-31 | -99.70% |
| 2023-12-31 | -81.19% |
| 2023-09-30 | -105.55% |
| 2023-06-30 | -189.42% |
| 2023-03-31 | -146.53% |
| 2022-12-31 | -119.50% |
| 2022-09-30 | -122.53% |
| 2022-06-30 | -138.04% |
| 2022-03-31 | -110.32% |
| 2021-12-31 | -82.75% |
| 2021-09-30 | -180.44% |
| 2021-06-30 | -156.47% |
| 2021-03-31 | -172.92% |
| 2020-12-31 | -120.32% |
| 2020-09-30 | -278.32% |
| 2020-06-30 | -67.94% |
| 2020-03-31 | -77.00% |
| 2019-12-31 | -52.22% |
| 2019-09-30 | -45.70% |
| 2019-06-30 | -46.26% |
| 2019-03-31 | -47.96% |
| 2018-12-31 | -62.25% |
| 2018-09-30 | -60.50% |
| 2018-06-30 | -54.20% |
| 2018-03-31 | -47.20% |
| 2017-12-31 | -41.83% |
| 2017-09-30 | -38.55% |
| 2017-06-30 | -39.38% |
| 2017-03-31 | -39.78% |
| 2016-12-31 | -39.80% |
| 2016-09-30 | -54.06% |
| 2016-06-30 | -55.54% |
| 2016-03-31 | -67.31% |
